In silico screening predicts common cold drug Dextromethorphan along with Prednisolone and Dexamethasone can be effective against novel Coronavirus disease (COVID-19)
- 23 November 2020
- journal article
- research article
- Published by Taylor & Francis in Journal of Biomolecular Structure and Dynamics
- Vol. 40 (8) , 3706-3710
Abstract
The ongoing outbreak of Coronavirus disease 2019 (COVID-19) is a matter of great concern. Although the mortality rate caused by this virus is less than that of SARS and MERS, it is showing higher efficacy in terms of human-to-human transmission. Several strategies have been taken by scientists and researchers worldwide to combat this virus. Numerous phytochemicals and synthesized chemicals are under incessant inspection to obtain a potent anti-covid drug. Since, till now no precise therapy is available for covid patients, researchers are trying to categorize all possible anti-covid substances. Repurposing of drugs and combined drug therapy are becoming popular in treating such viral diseases. In this study, we are proposing the repurposing of three chemicals-Dextromethorphan, Prednisolone and Dexamethasone as anti-covid agents. We have used the tertiary structure of Coronavirus main protease (Mpro) with PDB ID 6LU7 as the target protein in this analysis. Molecular docking and dynamics study further revealed their synergistic effect against the COVID-19 protease protein. Communicated by Ramaswamy H. SarmaKeywords
Funding Information
- department of biotechnology, Govt. of West Bengal
This publication has 20 references indexed in Scilit:
- COVID-19, SARS and MERS: are they closely related?Clinical Microbiology and Infection, 2020
- On the Alert for Cytokine Storm: Immunopathology in COVID‐19Arthritis & Rheumatology, 2020
- Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigationsJournal of Biomolecular Structure and Dynamics, 2020
- COVID-19 infection and rheumatoid arthritis: Faraway, so close!Autoimmunity Reviews, 2020
- Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19Journal of Biomolecular Structure and Dynamics, 2020
- COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection?Aging, 2020
- Consistent thermostatistics forbids negative absolute temperaturesNature Physics, 2013
- GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitBioinformatics, 2013
- Antitussive activity of sigma‐1 receptor agonists in the guinea‐pigBritish Journal of Pharmacology, 2004
- Dextromethorphan An Overview of Safety IssuesDrug Safety, 1992